Please login to the form below

Not currently logged in


This page shows the latest CAR-T news and features for those working in and with pharma, biotech and healthcare.

BMS and 2seventy bio move away from CAR-T programme

BMS and 2seventy bio move away from CAR-T programme

After forming a partnership to develop a multiple myeloma CAR-T cell therapy, Bristol Myers Squibb (BMS) and 2seventy bio have announced that the development plans have been scrapped, while sales ... Abecma, approved in March 2021 as the first BCMA CAR-T

Latest news

More from news
Approximately 56 fully matching, plus 167 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 59 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • The heavy toll of COVID-19 on cancer patients

    For example, all CAR-T cell therapies were paused as intensive care unit beds were needed to help COVID-19 patients recover. ... People who aren’t diagnosed with cancer as early as they might have been pre-pandemic, may not die for several years.

  • October 2020: diversity and inclusion in clinical trials round-up October 2020: diversity and inclusion in clinical trials round-up

    more — who don’t have the luxury to work from home, have groceries delivered, or socially isolate themselves; and those who depend on public transportation to get to work, and thus ... can’t travel safely in their car, or afford parking when they

  • In the precision medicine era, the line between products and services is blurred

    CAR-T is a new individualised cancer immunotherapy that has taken precision medicine to a new level. ... Both of these scenarios were true in the case of the CAR-T treatment.

  • The impossible launch

    SpaceX is inspiring people in a way that NASA hasn’t managed in over 30 years. ... Today’s therapy advances, such as CAR-T and gene therapy, are just as exciting and will help shape our world in the years to come.

  • Perspective: the patient edition

    The ALS patient journey. An article on CAR-T service design. Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.

More from PMHub
Approximately 4 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...